14-50621893-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PS1_Very_StrongPM1PM2PM5PP2PP3PP5_Moderate
The NM_015915.5(ATL1):c.1041G>T(p.Met347Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M347T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_015915.5 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 3AInheritance: AD, SD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- neuropathy, hereditary sensory, type 1DInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- hereditary sensory and autonomic neuropathy type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015915.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATL1 | NM_015915.5 | MANE Select | c.1041G>T | p.Met347Ile | missense | Exon 10 of 14 | NP_056999.2 | ||
| ATL1 | NM_001127713.1 | c.1041G>T | p.Met347Ile | missense | Exon 11 of 14 | NP_001121185.1 | |||
| ATL1 | NM_181598.4 | c.1041G>T | p.Met347Ile | missense | Exon 10 of 13 | NP_853629.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATL1 | ENST00000358385.12 | TSL:1 MANE Select | c.1041G>T | p.Met347Ile | missense | Exon 10 of 14 | ENSP00000351155.7 | ||
| ATL1 | ENST00000441560.6 | TSL:1 | c.1041G>T | p.Met347Ile | missense | Exon 11 of 14 | ENSP00000413675.2 | ||
| ATL1 | ENST00000682037.1 | c.1041G>T | p.Met347Ile | missense | Exon 10 of 14 | ENSP00000508289.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 3A Pathogenic:1
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.74; 3Cnet: 0.86). Different nucleotide change resulting in same amino acid change has been previously reported to be associated with ATL1 related disorder (PMID: 31594988). Different missense changes at the same codon (p.Met347Leu, p.Met347Thr) have been reported to be associated with ATL1 related disorder (PMID: 21321493, 28736820). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at